The NittoPhase™ Platform
For more than 20 years, Unylinker™ 350 has been Kinovate Life Sciences’ most recognized product. As a part of the NittoPhase™ product family, it is built on advanced polymer synthesis technology to serve as a robust solid support for therapeutic oligonucleotide synthesis— delivering industry-leading performance at a significantly reduced cost.
Nitto’s proprietary cross-linked polystyrene formulation provides exceptional structural integrity, enabling higher yields, improved purity, and lower cost per unit. As a result, NittoPhase™ supports both small and large-scale oligonucleotide synthesis while positively impacting overall process efficiency, cost control, and product quality.






